Uptake of 111in-Z2D3 on SPECT imaging in a swine model of coronary stent restenosis correlated with cell proliferation

Journal of Nuclear Medicine

Volumn 45, Issue 2, 2004, Pages 294-299

  Johnson, Lynne L ^a,d   Schofield, Lorraine M ^a   Weber, Deena K ^b   Kolodgie, Frank ^b   Virmani, Renu ^b   Khaw, Ban An ^c  

^a BROWN UNIVERSITY   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

Coronary artery; In stent restenosis; Radiolabeled antibody fragments; Smooth muscle cells

Indexed keywords

BROXURIDINE; CLOPIDOGREL; DIETHYLENETRIAMINEPENTAACETIC ACID POLYLYSINE; INDOMETACIN; MONOCLONAL ANTIBODY Z2D3 IN 111; POLYLYSINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VERAPAMIL; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; INDIUM; INDIUM 111 CT84.66 MONOCLONAL ANTIBODY; INDIUM 111-CT84.66 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY STENT; CORRELATION ANALYSIS; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RESTENOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; CELL DIVISION; IMAGE PROCESSING; INTIMA; MALE; PATHOLOGY; SCINTISCANNING; STENT; SWINE; TUNICA MEDIA;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIVISION; CORONARY RESTENOSIS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOGLOBULIN G; INDIUM RADIOISOTOPES; MALE; STENTS; SWINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUNICA INTIMA; TUNICA MEDIA;

EID: 1542714222     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Srinivas VS, Brooks MM, Detre KM, et al. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study. Circulation. 2002;106:1627-1633.
2. Morice MC, Serruys PW, Sousa E, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1173-1180.
3. Austin GE, Ratliff NB, Hollman J, et al. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;6:369-375.
4. Harrison DC, Calenoff E, Chen FW, et al. Plaque associated immune reactivity as a tool for the diagnosis and treatment of atherosclerosis. Trans Am Clin Climatol Assoc. 1992;103:210-207.
5. Narula J, Petrov A, Bianchi C, et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 f(ab′)2 specific for the proliferating smooth muscle cells for human atheroma: imaging with conventional and negative charge modified antibody fragments. Circulation. 1995;92:474-484.
6. Khaw B-A, Klibanov A, O'Donnell SM, et al. Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med. 1991;32:1742-1751.
7. Torchilin VP, Klibanov A, Nosiff ND, et al. Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding. Hybridoma. 1987;6:229-240.
8. Johnson L, Schofield LM, Verdesca SA, et al. In vivo uptake of radiolabeled antibody to proliferating smooth muscle cells in a swine model of coronary stent restenosis. J Nucl Med. 2000;41:1535-1540.
9. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part I. Historical perspectives, histochemical methods and cell kinetics. Histochem J. 1995;27:339-369.
10. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization. Histochem J. 1995;28:531-575.
11. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part II. Oncology, chemotherapy and carcinogenesis. Histochem J. 1995;27:923-964.
12. Carter AJ, Laird JR, Farb A, et al. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol. 1994;24:1398-1400.
13. Farb A, Weber DK, Kolodgie FD, et al. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105:2974-2980.
14. Farb A, Santiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99:44-52.
15. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428-1436.
16. Prisco D, Fedi S, Antonucci E, et al. Post-procedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA. Thromb Res. 2002;104:181-186.
17. Shimada K, Miyauchi K, Mokuno H, et al. Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting. Jpn Heart J. 2002;43:85-91.
18. Imai K, Matsubara T, Kanashiro M, et al. Lipid peroxidation may predict restenosis after coronary balloon angioplasty. Jpn Circ J. 2001;65:494-499.
19. Nageh T, DeBelder AJ, Thomas MR, et al. Intravascular ultrasound-guided stenting in long lesions: an insight into possible mechanisms of restenosis and comparison of angiographic and intravascular ultrasound data from the MUSIC and RENEWAL Trials. J Interv Cardiol. 2001;14:397-405.
20. Sardanelli F, Zandrino F, Molinari G, et al. MR evaluations of coronary stents with navigator echo and breath-hold cine gradient-echo techniques. Eur Radiol. 2002;12:193-200.
21. Saito Y, Sakuma H, Shibata M, et al. Assessment of coronary flow velocity reserve using fast velocity-encoded cine MRI for noninvasive detection of restenosis after coronary stent implantation. J Cardiovasc Magn Reson. 2001;3:209-214.
22. Al-Saadi N, Nagel E, Gross M, et al. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2000;36:1557-1564.
23. Narula J, Petrov A, O'Donnell SM, et al. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in-vivo target localization. J Nucl Cardiol. 1996;3:231-241.
24. Narula J, Petrov A, Ditlow C, Pak K-Y, Chen FW, Khaw B-A. Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting. J Nucl Cardiol. 1997;4:226-233.
25. 90Y-biotin pretargeting method for radioimmunotherapy (RAIT) of colorectal cancer [abstract]. J Nucl Med. 2000;41(suppl):270P.
26. 188Re-labeled peptide. Bioconjugate Chemistry. 2000;11:842-854.
27. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334-1336.